ChemBridge Corp. and ChemBridge Research Laboratories, Inc. (CRL) have entered into a multi-year chemistry discovery collaboration with AstraZeneca. Under the agreement ChemBridge and CRL scientists at Moscow and San Diego research sites will work with AZ scientists to develop highly advanced exclusive small molecule libraries enhancing AZ’s global drug discovery effort. Further details and financial terms were not disclosed. “We are very pleased that after worldwide evaluation ...